Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

UK dividends calendar - next 7 days

3rd Aug 2023 15:45

Read More

LONDON MARKET OPEN: StanChart, AstraZeneca lift FTSE 100 into green

28th Jul 2023 08:52

(Alliance News) - Stock prices in London opened higher on Friday, boosted by a mostly strong set of company earnings, while investors weighed recent central bank decisions. Read More

TOP NEWS: AstraZeneca profit surges as Alexion agrees Pfizer deal

28th Jul 2023 08:51

(Alliance News) - AstraZeneca PLC on Friday reported half-year profit more than quintupling amid much lower costs, as its rare disease focused unit Alexion signed an agreement with Pfizer. Read More

LONDON BRIEFING: NatWest posts interim growth; IAG swings to profit

28th Jul 2023 07:54

(Alliance News) - Stocks in London are called slightly lower on Friday, with investors having plenty to consider amid the week's swathe of corporate earnings and central bank decisions. Read More

IN BRIEF: Astra drug approved while another shows promise

27th Jul 2023 21:08

AstraZeneca PLC - Cambridge-based pharmaceutical firm - Says Soliris approved in EU for treatment of refractory generalised myasthenia gravis in those aged between six and 17. "This is the first and only targeted therapy approved for the treatment of paediatric patients with the disease in the EU," AstraZeneca says. Myasthenia gravis is a disease that causes muscle weakness. Separately, Astra says Enhertu shows meaningful progression-free survival and overall survival in some cancer sufferers. The measures are two secondary endpoints of a phase II trial. Enhertu is being jointly-developed by Astra and Daiichi Sankyo Co Ltd. Read More

IN BRIEF: OTAQ names interim finance chief with incumbent to move on

25th Jul 2023 12:07

OTAQ PLC - Lancaster, England-based marine technology company, focused on offshore oil and gas industries and aquaculture - Chief Financial Officer Matt Enright resigns effective July 31, to assume a new role outside OTAQ. He was hired as CFO in April 2020. OTAQ appoints Justine Dowds, previously managing director at GB3 Ltd until May, as interim CFO. Dowds was also finance director at Pool Aviation Ltd from 2007 to 2015, and prior to that was financial controller at United Utilities Group PLC and an accountant at AstraZeneca PLC. Enright says: "I believe the company is now well placed to benefit from the investments in resource and products made over the past three years, placing OTAQ on a sound growth path." Read More

LONDON BRIEFING: Ocado backs annual guidance as interim loss widens

18th Jul 2023 07:48

(Alliance News) - Stocks in London are set to tread water on Tuesday, as investors look ahead to US corporate earnings and economic data. Read More

Rishi Sunak to meet bosses at inaugural Business Council gathering

18th Jul 2023 06:04

(Alliance News) - Bosses from AstraZeneca PLC, Alphabet Inc's Google, Shell PLC and other major companies will gather in Downing Street on Tuesday for the first meeting of Rishi Sunak's Business Council. Read More

US FDA approves AstraZeneca and Sanofi's Beyfortus for RSV in infants

17th Jul 2023 19:33

(Alliance News) - AstraZeneca PLC and Sanofi SA on Monday said the US Food & Drug Administration has approved the use of Beyfortus, or nirsevimab, in the US. Read More

LONDON BROKER RATINGS: HSBC says 'buy' AstraZeneca but 'reduce' GSK

14th Jul 2023 09:13

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday: Read More

LONDON MARKET OPEN: Stocks mixed ahead of US bank earnings

14th Jul 2023 08:56

(Alliance News) - Stock prices in London opened mixed on Friday, after a strong run this week, while investors wait to see how major US banks fared in the second quarter of the year. Read More

LONDON BRIEFING: Burberry shines in China; ITV-All3Media deal unlikely

14th Jul 2023 07:56

(Alliance News) - Stocks in London are expected to slip into the red at Friday's open, in a tepid conclusion to what has been a largely positive week for global equities, as the market prices in a lower peak for US interest rates. Read More

Astra, Daiichi get China approval for Enhertu breast cancer treatment

12th Jul 2023 12:08

(Alliance News) - Daiichi Sankyo Co Ltd on Wednesday its metastatic breast cancer treatment with AstraZeneca PLC was approved in China as a monotherapy for adult patients. Read More

LONDON BROKER RATINGS: UBS raises AstraZeneca; RBC cuts Bunzl

12th Jul 2023 09:27

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

LONDON MARKET OPEN: FTSE 100 higher as UK banks pass BoE stress tests

12th Jul 2023 08:45

(Alliance News) - European markets were trading higher on Wednesday, in a sign of cautious optimism ahead of US inflation data. Read More

LONDON BRIEFING: UK banks pass stress test; Wetherspoon trades well

12th Jul 2023 07:40

(Alliance News) - Stocks in London are called higher on Wednesday, ahead of US inflation data. Read More

LONDON MARKET CLOSE: FTSE 100 ends rough week in tepid fashion

7th Jul 2023 16:55

(Alliance News) - Stock prices in Europe diverged on Friday, with the FTSE 100 underperforming, as a weaker-than-expected US jobs report did little for equities amid the expectation that the Federal is not done with hiking. Read More

LONDON BROKER RATINGS: UBS likes Pearson; Liberum cuts Naked Wine

5th Jul 2023 09:34

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

LONDON MARKET CLOSE: Tepid close after quiet day with US market closed

4th Jul 2023 16:49

(Alliance News) - Stocks in London were largely higher on Tuesday, though the FTSE 100 slipped into the red amid weakness, while US markets were shut for the independence day holiday. Read More

LONDON MARKET MIDDAY: Stocks higher amid US holiday-thinned trade

4th Jul 2023 12:08

(Alliance News) - Stock prices in London were higher at midday on Tuesday, with the absence of US markets and any major economic releases keeping trade muted. Read More

FTSE 100 Latest
Value8,809.74
Change53.53